T-THERAPEUTICS
T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
T-THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2022-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.t-therapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
48 M GBP
Technology used in webpage:
Euro Host Europe
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Clade Therapeutics
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Investors List
Digitalis Ventures
Digitalis Ventures investment in Series A - T-Therapeutics
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Series A - T-Therapeutics
F-Prime Capital
F-Prime Capital investment in Series A - T-Therapeutics
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series A - T-Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - T-Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series A - T-Therapeutics
Official Site Inspections
http://www.t-therapeutics.com
- Host name: 25.26.205.92.host.secureserver.net
- IP address: 92.205.26.25
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "T-Therapeutics"
Home - T-Therapeutics
T-Therapeutics is driven by a profound purpose: we harness the natural power of T cells to attack and destroy tumours. We achieve this by discovering and developing T cell receptor-based …See details»
T-Therapeutics - Crunchbase Company Profile & Funding
Organization. T-Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... T …See details»
T-Therapeutics Ltd - Org Chart, Teams, Culture & Jobs - The Org
T-Therapeutics is a venture-backed company on a mission to unlock the power of T cells to treat chronic and infectious diseases. Based on technology from Professor Allan Bradley’s …See details»
Org Chart T-Therapeutics - The Official Board
Organizational Chart of T-Therapeutics. T-Therapeutics t-therapeutics.com. has 12 executives +44 208 037 2308; Add an executive. T-Therapeutics News . Anything missing? We search for …See details»
About - T-Therapeutics
T-Therapeutics is an Equal Opportunity employer. We will consider all applicants without discrimination on grounds of disability, sexual orientation, pregnancy or maternity leave status, …See details»
Team - T-Therapeutics
About T-Therapeutics. T-Therapeutics Abington Hall Granta Park Cambridge CB21 6ALSee details»
T-Therapeutics Company Profile 2024: Valuation, …
The company' proprietary T cell receptors (TCR) discovery platform, a very heavily humanised mouse, which gives access to TCRs for human antigens which are not available from human samples binds specific pMHC targets on …See details»
T-THERAPEUTICS LIMITED Company Profile - Dun & Bradstreet
T-therapeutics limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / …See details»
T-Therapeutics - Contacts, Employees, Board Members
Organization. T-Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and …See details»
T-Therapeutics - Company Profile - Tracxn
Oct 30, 2024 T-Therapeutics ranks 151st among 641 active competitors. 237 of its competitors are funded while 153 have exited. Overall, T-Therapeutics and its competitors have raised …See details»
T-Therapeutics - Funding, Financials, Valuation
Nov 15, 2023 T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much funding has this …See details»
T-Therapeutics - VentureRadar
T-KNIFE Germany Privately Held T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer. The company is initially focused on T cell …See details»
T-Therapeutics – Startups.Bio
Apr 21, 2023 T-Therapeutics is on a mission to unlock the power of T cells to treat chronic and infectious diseases.. Founded in 2022, the company is based on technology from Professor …See details»
T-Therapeutics - Raised $59.4M Funding from 6 investors - Tracxn
Dec 13, 2024 T-Therapeutics has raised a total funding of $59.4M over 1 round from 6 investors. Investors include F-Prime Capital, Sofinnova Partners and 4 others. Their latest funding round …See details»
T-Therapeutics - Products, Competitors, Financials, Employees ...
T-Therapeutics has an unusually strong and unique scientific foundation that is being leveraged to build a pipeline of transformative medicines. The team have an excellent track record of …See details»
Platform - T-Therapeutics
T-Therapeutics is developing next generation transformative medicines that target specific disease markers: first in cancer, and in time autoimmune and infectious diseases. We are able …See details»
T-Therapeutics Ltd - LinkedIn
T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science. We are developing ‘optimal’ TCR based …See details»
T-Therapeutics - Cambridge Innovation Capital
T cells are an important part of the immune system, playing a critical role in the response to infected, foreign or altered cells. ... T-Therapeutics is developing soluble T-cell receptor (TCR) …See details»
T-Therapeutics - businessweekly.co.uk
Nov 24, 2024 T-Therapeutics is a University of Cambridge spin-out that develops novel T cell receptor (TCR)-based treatments for cancer and autoimmune diseases. David Hung. Courtesy …See details»
Harnessing the biology of regulatory T cells to treat disease
6 days ago Regulatory T cells keep the immune system in check to maintain homeostasis and restrain inflammation. This Review discusses strategies to harness these cells therapeutically …See details»